151 related articles for article (PubMed ID: 17571419)
21. Nephropathy in Fabry disease: the importance of early diagnosis and testing in high-risk populations.
Oqvist B; Brenner BM; Oliveira JP; Ortiz A; Schaefer R; Svarstad E; Wanner C; Zhang K; Warnock DG
Nephrol Dial Transplant; 2009 Jun; 24(6):1736-43. PubMed ID: 19293136
[No Abstract] [Full Text] [Related]
22. [CME. Fabry disease: rare but not to be missed].
Steinack C; Gaspert A; Kovacs R; Nowak A
Praxis (Bern 1994); 2015 Jul; 104(14):719-29. PubMed ID: 26135721
[No Abstract] [Full Text] [Related]
23. [Heart failure associated with ischemic cardiomyopathy].
Ogawa T
Nihon Rinsho; 2007 May; 65 Suppl 5():413-20. PubMed ID: 17571414
[No Abstract] [Full Text] [Related]
24. [Heart failure due to dilated cardiomyopathy].
Hiramitsu S; Miyagishima K; Mori K; Kimura H
Nihon Rinsho; 2007 May; 65 Suppl 5():421-4. PubMed ID: 17569321
[No Abstract] [Full Text] [Related]
25. [Priapism: a severe paediatric complication of Fabry disease].
Labarthe F; de Bodman C; Maruani A; Szwarc C; Froissart R; Lorette G; Lardy H
Rev Med Interne; 2010 Dec; 31 Suppl 2():S217-9. PubMed ID: 21211667
[TBL] [Abstract][Full Text] [Related]
26. Enzyme replacement therapy in an adolescent with Fabry disease.
Illsinger S; Luecke T; Langen H; Das AM
Eur J Pediatr; 2003 Jul; 162(7-8):522-523. PubMed ID: 12733069
[No Abstract] [Full Text] [Related]
27. An expert consensus document on the management of cardiovascular manifestations of Fabry disease.
Linhart A; Germain DP; Olivotto I; Akhtar MM; Anastasakis A; Hughes D; Namdar M; Pieroni M; Hagège A; Cecchi F; Gimeno JR; Limongelli G; Elliott P
Eur J Heart Fail; 2020 Jul; 22(7):1076-1096. PubMed ID: 32640076
[TBL] [Abstract][Full Text] [Related]
28. Fabry disease: focus on cardiac manifestations and molecular mechanisms.
Perrot A; Osterziel KJ; Beck M; Dietz R; Kampmann C
Herz; 2002 Nov; 27(7):699-702. PubMed ID: 12439642
[TBL] [Abstract][Full Text] [Related]
29. Can cardiac-resynchronization therapy reduce mortality in patients suffering from advanced chronic heart failure?
Cleland JG; Ghosh J; Freemantle N
Nat Clin Pract Cardiovasc Med; 2004 Nov; 1(1):10-1. PubMed ID: 16265249
[No Abstract] [Full Text] [Related]
30. [New trends in therapy for chronic congestive heart failure].
Hori M
Nihon Naika Gakkai Zasshi; 2005 Feb; 94(2):187-9. PubMed ID: 15768578
[No Abstract] [Full Text] [Related]
31. Anderson-Fabry disease and the heart.
O'Mahony C; Elliott P
Prog Cardiovasc Dis; 2010; 52(4):326-35. PubMed ID: 20109602
[TBL] [Abstract][Full Text] [Related]
32. The heart in Anderson Fabry disease.
Kampmann C; Wiethoff CM; Perrot A; Beck M; Dietz R; Osterziel KJ
Z Kardiol; 2002 Oct; 91(10):786-95. PubMed ID: 12395219
[TBL] [Abstract][Full Text] [Related]
33. Early therapeutic intervention in females with Fabry disease?
Hughes DA
Acta Paediatr; 2008 Apr; 97(457):41-7. PubMed ID: 18339187
[TBL] [Abstract][Full Text] [Related]
34. [Fabry-Anderson disease: current state of knowledge].
Vega-Vega O; Pérez-Gutiérrez A; Correa-Rotter R
Rev Invest Clin; 2011; 63(3):314-21. PubMed ID: 21888295
[TBL] [Abstract][Full Text] [Related]
35. Spotlight on agalsidase beta in Fabry disease.
Keating GM; Simpson D
BioDrugs; 2007; 21(4):269-71. PubMed ID: 17628124
[TBL] [Abstract][Full Text] [Related]
36. [Intravenous lidocaine as treatment for the painful episodes in Fabry's disease].
Politei JM
Rev Neurol; 2009 Aug 1-15; 49(3):166-7. PubMed ID: 19621314
[No Abstract] [Full Text] [Related]
37. Anemia is a new complication in Fabry disease: data from the Fabry Outcome Survey.
Kleinert J; Dehout F; Schwarting A; de Lorenzo AG; Ricci R; Kampmann C; Beck M; Ramaswami U; Linhart A; Gal A; Houge G; Widmer U; Mehta A; Sunder-Plassmann G
Kidney Int; 2005 May; 67(5):1955-60. PubMed ID: 15840043
[TBL] [Abstract][Full Text] [Related]
38. [The evolution of nephrology: from the theory of humors to gene therapy].
Morales Buenrostro LE; Correa-Rotter R
Rev Invest Clin; 2003; 55(2):200-6. PubMed ID: 12827928
[No Abstract] [Full Text] [Related]
39. [Congestive heart failure and arrhythmia].
Kasanuki H
Nihon Rinsho; 1993 May; 51(5):1354-61. PubMed ID: 8101240
[TBL] [Abstract][Full Text] [Related]
40. Improvement of cardiac hypertrophy and ventricular function in a man with Fabry disease by treatment with recombinant alpha-galactosidase A.
Komamura K; Higashi M; Yamada N
Heart; 2004 Jun; 90(6):617. PubMed ID: 15145857
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
